logo

For the Inventor, By the Inventor

Toronto, Canada

Tony Cruz

This inventor holds 5 USPTO granted patents. Top assignee: Transition Therapeutics, Inc.. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tony Cruz. Retrieved from https://idiyas.com/inventor/tony-cruz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal5 out of 7 
 
Transition Therapeutics, Inc.
 patents

Years Active: 2004-2006

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7026355 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2006-04-11),
2. 6911429 - Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans (2005-06-28),
3. 6908611 - Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases (2005-06-21),
4. 6894033 - Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases (2005-05-17),
5. 6797727 - Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases (2004-09-28),

Title: The Innovative Contributions of Tony Cruz

Introduction

Tony Cruz is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of vascular diseases and cellular response to injury. With a total of 5 patents to his name, Cruz continues to push the boundaries of innovation in healthcare.

Latest Patents

Cruz's latest patents include groundbreaking inventions that focus on the use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases. This invention addresses critical issues such as blood vessel restenosis and atherosclerosis, which obstruct the vascular system. Another significant patent involves compositions and methods for treating cellular responses to injury and proliferating cell disorders regulated by hyaladherin and hyaluronans. This invention provides methods for addressing tissue disorders associated with a novel cellular phenotype known as 'transition cells.' These advancements highlight Cruz's commitment to improving medical treatments and patient outcomes.

Career Highlights

Throughout his career, Tony Cruz has been associated with Transition Therapeutics, Inc., where he has played a pivotal role in developing innovative therapeutic solutions. His work has not only contributed to the scientific community but has also paved the way for new treatment options for patients suffering from various medical conditions.

Collaborations

Cruz has collaborated with talented individuals such as Aleksandra Pastrak and Eva Anne Turley. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in the medical field.

Conclusion

Tony Cruz's contributions to medical research and innovation are commendable. His patents reflect a deep understanding of complex medical issues and a commitment to finding effective solutions. As he continues to work in the field, his impact on healthcare will undoubtedly grow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…